Beijing Konruns Pharmaceutical Co Ltd (603590) — Cash Flow Quality Index
Beijing Konruns Pharmaceutical Co Ltd (603590) has a Cash Flow Quality Index of 2.62x as of September 2025. Operating cash flow of CN¥96.44 Million exceeds net income of CN¥36.83 Million, indicating high earnings quality where cash backs reported profits. Explore 603590 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Konruns Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Beijing Konruns Pharmaceutical Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Beijing Konruns Pharmaceutical Co Ltd (603590) cash flow conversion.
Annual Cash Flow Quality Index for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Beijing Konruns Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥115.68 Million | CN¥165.97 Million | ▼ -91.3% |
| 2024 | 8.00x | CN¥172.25 Million | CN¥21.53 Million | ▲ +652.7% |
| 2023 | 1.06x | CN¥199.35 Million | CN¥187.57 Million | ▲ +10.0% |
| 2022 | 0.97x | CN¥119.69 Million | CN¥123.89 Million | ▲ +128.1% |
| 2021 | 0.42x | CN¥70.91 Million | CN¥167.44 Million | ▲ +33.0% |
| 2020 | 0.32x | CN¥58.41 Million | CN¥183.35 Million | ▼ -67.7% |
| 2019 | 0.98x | CN¥262.00 Million | CN¥266.08 Million | ▼ -1.2% |
| 2018 | 1.00x | CN¥263.11 Million | CN¥263.93 Million | ▲ +76.5% |
| 2017 | 0.56x | CN¥270.49 Million | CN¥478.82 Million | ▼ -27.0% |
| 2016 | 0.77x | CN¥148.26 Million | CN¥191.65 Million | ▼ -21.3% |
| 2015 | 0.98x | CN¥191.80 Million | CN¥195.25 Million | ▲ +31.9% |
| 2014 | 0.74x | CN¥130.98 Million | CN¥175.86 Million | ▼ -45.9% |
| 2013 | 1.38x | CN¥163.72 Million | CN¥118.95 Million | — |